Editorial
Discontinuing anticytomegalovirus therapy in patients with cytomegalovirus retinitis and AIDS
| The first 150 words of the full text of this article appear below. |
Cytomegalovirus (CMV) retinitis is the most common opportunistic ocular infection in patients with the acquired immune deficiency syndrome (AIDS).1 Before the advent of highly active antiretroviral therapy (HAART), CMV retinitis affected 30% of patients with AIDS at some time during the course of their disease.2 Cytomegalovirus retinitis is a late stage complication associated with low CD4+ T cell counts, typically less than 50 cells × 106/l.3 4 Cytomegalovirus retinitis was rare at CD4+ T cells >100 cells × 106/l.3 4 All of the available anti-CMV therapies suppress viral replication, but do not eliminate the virus. Unless immune reconstitution occurs, prolonged suppressive anti-CMV therapy (maintenance therapy) is required.1 5 Without immune reconstitution or maintenance therapy, CMV retinitis relapses within 3 weeks. As such, in the pre-HAART era, patients with CMV retinitis required lifetime maintenance anti-CMV therapy.
HAART consists of combination therapy for the human immunodeficiency
virus (HIV), with at least three drugs, typically two nucleoside
reverse transcriptase inhibitors
Relevant Article
- Suspension of anticytomegalovirus maintenance therapy following immune recovery due to highly active antiretroviral therapy
- André L L Curi, Acácio Muralha, Lilia Muralha, and Carlos Pavesio
Br. J. Ophthalmol. 2001 85: 471-473.[Abstract] [Full Text] [PDF]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
